Semaglutide Dosing Chart: Understanding Weekly Schedules for Ozempic and Wegovy

A semaglutide dosing chart helps patients understand how prescription treatment schedules differ between medications used for type 2 diabetes and chronic weight management. Although Ozempic and Wegovy contain the same active ingredient, their approved dosing schedules and treatment goals are not identical.

Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist class. It helps regulate blood glucose, influences appetite, and supports metabolic health.

Most injectable semaglutide treatment plans begin with a low introductory dose and increase gradually. This approach helps improve tolerability while allowing healthcare professionals to assess treatment response.

What Is a Semaglutide Dosing Chart?

A semaglutide dosing chart is a reference showing medication strengths, treatment stages, and administration frequency.

Healthcare professionals use approved prescribing information to determine the appropriate schedule for each patient.

The correct regimen depends on the specific product, medical indication, previous treatment response, and individual tolerability.

Therefore, charts should be treated as educational references rather than instructions for independently changing medication.

Ozempic Semaglutide Dosing Chart for Type 2 Diabetes

Ozempic is a once-weekly injectable semaglutide medication prescribed for certain adults with type 2 diabetes and other approved indications.

Its standard dose-escalation schedule begins with an introductory period before patients move to a maintenance dose.

Treatment StageTypical Weekly DosePurpose
Weeks 1–40.25 mgInitial treatment and tolerability
Week 5 onward0.5 mgInitial maintenance treatment
If further control is needed1 mgAdditional glycemic control
If clinically appropriate2 mgHigher maintenance option

The introductory 0.25 mg dose is not intended to provide full glycemic control.

Healthcare professionals determine whether subsequent increases are appropriate based on treatment response and adverse effects.

Patients should never increase their dose solely because a chart shows a higher available strength.

Wegovy Semaglutide Dosing Chart for Weight Management

Wegovy is prescribed for eligible patients with obesity or overweight accompanied by certain weight-related medical conditions.

The commonly used injectable Wegovy escalation schedule differs from Ozempic because it targets a different approved treatment regimen.

Treatment PeriodTypical Weekly Dose
Weeks 1–40.25 mg
Weeks 5–80.5 mg
Weeks 9–121 mg
Weeks 13–161.7 mg
Week 17 onward2.4 mg maintenance

This chart illustrates the established 2.4 mg escalation pathway. Product labeling may include other maintenance options or newer dosing provisions, depending on the formulation and jurisdiction.

If patients experience significant gastrointestinal symptoms, their prescribing clinician may delay escalation or adjust treatment according to approved guidance.

Why Do Semaglutide Doses Increase Gradually?

Semaglutide influences appetite regulation and slows gastric emptying.

These effects can contribute to nausea, vomiting, constipation, and abdominal discomfort, particularly when treatment begins.

Gradual escalation gives the body time to adapt.

For readers comparing a semaglutide dosing chart with other medication information, it is essential to verify the exact product, formulation, and prescribing instructions before interpreting dose values.

The same milligram quantity does not automatically mean two products are interchangeable.

How Often Should Semaglutide Be Administered?

Injectable Ozempic and Wegovy are generally administered once weekly.

Patients typically choose a consistent day of the week and follow the instructions supplied with their prescription.

The medication is administered subcutaneously, meaning beneath the skin.

Approved injection sites commonly include the abdomen, thigh, or upper arm.

Patients should rotate injection locations and follow product-specific handling instructions.

Oral semaglutide follows a different schedule and should not be included in weekly injection charts.

What Happens If You Miss a Weekly Dose?

Missed-dose instructions differ between Ozempic and Wegovy.

For Ozempic, prescribing information generally allows a missed dose to be taken within five days of the scheduled administration.

For Wegovy, instructions depend on how much time remains before the next scheduled dose.

Patients should consult their specific product label rather than applying one medication’s instructions to another.

If multiple consecutive doses have been missed, restarting treatment may require professional guidance.

Taking extra medication to compensate for missed doses can increase the risk of adverse reactions.

Important Safety Considerations

Semaglutide can cause gastrointestinal side effects, including nausea, diarrhea, vomiting, and constipation.

More serious concerns include pancreatitis, gallbladder problems, dehydration-related kidney injury, and severe gastrointestinal reactions.

Semaglutide products also carry a boxed warning concerning thyroid C-cell tumors observed in rodents.

They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Patients using insulin or certain diabetes medications may face an increased risk of hypoglycemia.

Medical supervision is necessary when adjusting treatment.

Can You Switch Between Ozempic and Wegovy?

Although both medications contain semaglutide, they have different approved indications and dosing instructions.

Switching formulations requires a healthcare professional to consider the current regimen, treatment goals, and potential adverse effects.

Patients should never substitute one product for another or calculate their own conversion schedule.

Final Thoughts

A semaglutide dosing chart provides a useful overview of how weekly treatment schedules progress from introductory doses to maintenance therapy.

However, Ozempic and Wegovy follow different prescribing pathways, and individual treatment plans may vary.

Patients should use dosing charts for general understanding while following their clinician’s instructions and the current prescribing information for their specific medication.

Related Posts